Apellis enters drug development and commercialisation deal with Sobi
Apellis Pharmaceuticals has entered into a strategic collaboration with Swedish Orphan Biovitrum (Sobi) to fast-track the advancement of systemic pegcetacoplan…
Latest deal
-
18 hours
-
2 days
-
3 days
-
3 days
-
18 hours
-
2 days
-
3 days
-
3 days
Aurobindo Pharma to sell US subsidiary to New Mountain Capital affiliate
Indian firm Aurobindo Pharma has entered into a definitive agreement to sell its US subsidiary Natrol to an affiliate of…
Latest News
View More
Apellis enters drug development and commercialisation deal with Sobi
Apellis Pharmaceuticals has entered into a strategic collaboration with Swedish Orphan Biovitrum (Sobi) to fast-track the advancement of systemic pegcetacoplan to treat multiple rare diseases…
Aurobindo Pharma to sell US subsidiary to New Mountain Capital affiliate
Indian firm Aurobindo Pharma has entered into a definitive agreement to sell its US subsidiary Natrol to an affiliate of New Mountain Capital in an…
Boehringer expands oncology partnership with Oxford BioTherapeutics
Boehringer Ingelheim has announced the expansion of its partnership with UK-based Oxford BioTherapeutics (OBT) to discover novel selective targets for strategic…
Rhizen signs oncology drug development deal with Curon
Swiss biopharma company Rhizen Pharmaceuticals has signed an exclusive licensing agreement with Curon Biopharmaceutical to develop and commercialise Tenalisib for…
Pfizer completes $200m investment in CStone
CStone Pharmaceuticals has completed the previously announced share subscription agreement through which a Pfizer affiliate subscribed for newly issued CStone…
Pfizer and BioNTech enter Covid-19 vaccine deal with New Zealand
Pfizer and BioNTech have entered an agreement with the New Zealand Government to supply 1.5 million doses of their potential…
Company A-Z
View More
SIRION Biotech
Customised Viral Vectors for Cell Modelling, Gene Therapy, and Vaccination Research and Development
Cytiva (formerly GE Life Sciences)
Bioprocessing Solutions for Development and Manufacture of Biotherapeutics and Vaccines
Latest Content
View More
Tackling fibrosis: Galecto raises $64m in equity financing
Copenhagen-headquartered biotech and fibrosis specialist Galecto has completed a $64m equity financing. This round was co-led by Soleus Capital and…
Pfizer and BioNTech enter Covid-19 vaccine deal with New Zealand
Pfizer and BioNTech have entered an agreement with the New Zealand Government to supply 1.5 million doses of their potential…
Efficient Substance Identification Using Identify
The NETZSCH Database for Curve Recognition and Comparison of Measurement Curves It is possible to identify substances manually by comparing…
Gerresheimer Expands Range of Services in Asia
Medical technology specialist Gerresheimer is pleased to announce that it is extending its services portfolio in Asia. To date, injection…
Free Rheology Webinars Available Now
Did you out on any of our rheology webinars the took place earlier this year? Watch them now for free!…
VHP Decontamination
Castium ‘Hydrogen Peroxide Bio-decontamination service’ uses pre-qualified mobile bio-decontamination equipment that meets all of the new EU regulatory standards including…